Skip to content

Author

Hai-Ying Cheng

We have 2 of 30 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Nivolumab and Cabozantinib in People with HIV and Advanced Solid Tumors: A Pilot Trial and Systematic Review.

BACKGROUND People living with HIV (PWH) are underrepresented in immune checkpoint inhibitor (ICI) and targeted therapy trials, despite a growing burden of malignancies. Cabozantinib may remodel the tumor microenvironment by reducing immunosuppressive myeloid populations and enhancing cytotoxic T-cell infiltration, ther...

Hai-Ying Cheng, Ece Cali, Mumtu Lalla et al. · 0 citations
Review Open access Aug 2026

Update 2026: Management of Small Cell Lung Cancer

A clinically oriented overview of current standards and emerging therapeutic strategies in SCLC is provided, with attention to evidence quality, toxicity, sequencing, and clinical applicability.

Mumtu Lalla, P. Dhillon, Buse Eglenen Polat et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.